Elmind

XTLB uptrend to profitability

Long
NASDAQ:XTLB   XTL Biopharmaceuticals Ltd.
XTLB is going to consolidate a little at the current price before continuing on the up trend. We will buy once price pulls back to $3.02 or lower. Taking profits at various levels.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.